Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions

J Peripher Nerv Syst. 2014 Jun;19(2):88-103. doi: 10.1111/jns5.12074.

Abstract

Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) are thought to be autoimmune diseases. There have been many attempts to find a human leukocyte antigen (HLA) association with GBS and CIDP with little success. There have been studies of other plausible genes in GBS and CIDP and the role of these genes in GBS and CIDP and the data from these genetic studies is reviewed. Some of the genes that have been studied are immune related and some others have nervous system effects. The studies are limited by small numbers. Some of the genes show association with disease severity rather than disease susceptibility. The need for more detailed molecular studies of the role of HLA molecules and the need for modern genetic approaches to GBS and CIDP are explained.

Keywords: CD1; Guillain-Barré syndrome; TNF; chronic inflammatory demyelinating polyradiculoneuropathy; disease associations; genetics; major histocompatability complex.

MeSH terms

  • Genetic Association Studies* / methods
  • Genetic Association Studies* / trends
  • Genetic Predisposition to Disease / genetics*
  • Guillain-Barre Syndrome / genetics*
  • HLA Antigens / genetics
  • Humans
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / genetics*

Substances

  • HLA Antigens